Goldman Sachs
KYTH

Goldman Sachs’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Goldman Sachs’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-30,700
Closed -$2.3M – 7666
2015
Q3 		$2.3M Sell
30,700
-91,900
-75% -$6.86M ﹤0.01% 3645
2015
Q2 		$9.23M Buy
122,600
+119,600
+3,987% +$6.41M ﹤0.01% 2399
2015
Q1 		$150K Buy
+3,000
New +$126K ﹤0.01% 6209

Goldman Sachs's KYTH Position: Q4 2015 in Review

Goldman Sachs sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 81,373 shares — an estimated $6.1M sold.

Goldman Sachs first reported a position in KYTH in Q1 2014 and held it in 7 quarters. The position peaked at $6.1M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Goldman Sachs reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Goldman Sachs sold 81,373 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $6.1M.
  • Goldman Sachs first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 7 quarters.
  • Goldman Sachs's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $6.1M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Goldman Sachs's 13F filing for Q4 2015, filed 16 Feb 2016.